NCT06691256View on ClinicalTrials.gov

Preventing Medication Mismanagement in People Living with Dementia Through Automated Medication Dispensing with Facial Recognition and Video Observation

PHASE2Active, not recruitingINTERVENTIONAL
Enrollment

70

Participants

Timeline

Start Date

September 24, 2024

Primary Completion Date

May 31, 2026

Study Completion Date

May 31, 2026

Conditions
Alzheimer DiseaseDementiaMedication AdherenceType 2 Diabetes Mellitus (T2DM)
Interventions
DEVICE

HiDO-ALZ

HiDO-ALZ platform, an AI-driven medication dispensing and observation system designed to improve adherence in individuals with dementia and diabetes.

Trial Locations (1)

60612

Rush University Medical Center, Chicago

Sponsors

Lead Sponsor

HiDO Technologies
All Listed Sponsors
collaborator

Rush University Medical Center

OTHER

lead

HiDO Technologies

INDUSTRY

NCT06691256 - Preventing Medication Mismanagement in People Living with Dementia Through Automated Medication Dispensing with Facial Recognition and Video Observation | Biotech Hunter | Biotech Hunter